Genprex, Inc. (GNPX): Price and Financial Metrics
GNPX Price/Volume Stats
| Current price | $0.26 | 52-week high | $3.97 |
| Prev. close | $0.27 | 52-week low | $0.20 |
| Day low | $0.26 | Volume | 555,800 |
| Day high | $0.27 | Avg. volume | 3,244,185 |
| 50-day MA | $0.28 | Dividend yield | N/A |
| 200-day MA | $0.64 | Market Cap | 7.24M |
GNPX Stock Price Chart Interactive Chart >
Genprex, Inc. (GNPX) Company Bio
Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.
GNPX Price Returns
| 1-mo | -6.68% |
| 3-mo | -22.39% |
| 6-mo | -68.96% |
| 1-year | N/A |
| 3-year | -99.55% |
| 5-year | N/A |
| YTD | -69.47% |
| 2024 | -90.74% |
| 2023 | -84.14% |
| 2022 | 10.69% |
| 2021 | -68.43% |
| 2020 | 1,196.88% |
Loading social stream, please wait...